Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.

Fumoleau, P; Delgado, F M; Delozier, T; Monnier, A; Gil Delgado, M A; Kerbrat, P; Garcia-Giralt, E; Keiling, R; Namer, M; Closon, M T

Fumoleau, P; Delgado, F M; Delozier, T; Monnier, A; Gil Delgado, M A; Kerbrat, P; Garcia-Giralt, E; Keiling, R; Namer, M; Closon, M T.

Affiliation

Fumoleau P; Pierre Fabre Research Centre, Boulogne, France.

J Clin Oncol ; 11(7): 1245-52, 1993 Jul.

Article in En | MEDLINE | ID: mdl-8315421

Subject(s)

Adenocarcinoma/drug therapy; Antineoplastic Agents/therapeutic use; Breast Neoplasms/drug therapy; Vinblastine/analogs & derivatives; Adenocarcinoma/secondary; Adult; Aged; Antineoplastic Agents/administration & dosage; Antineoplastic Agents/adverse effects; Breast Neoplasms/pathology; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Middle Aged; Vinblastine/administration & dosage; Vinblastine/adverse effects; Vinblastine/therapeutic use; Vinorelbine

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vinblastine / Breast Neoplasms / Adenocarcinoma / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 1993 Document type: Article Affiliation country: France Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links